Headquartered in Glen Burnie, MD, NovaSom is a leader in Obstructive Sleep Apnea (“OSA”) home testing, with the AccuSom® home sleep test, the only comprehensively supported home sleep test that provides continuous patient support and next-day test results and interpretation.
The FDA-cleared AccuSom test is significantly more convenient and comfortable for the patient, compared to in-facility testing. Patients are able to test around their own schedule and can sleep in their own bed, which helps eliminate “first night” effect and improves data collection. AccuSom is currently covered for more than 150 million commercially insured U.S. lives.
Healthcare professionals have the option of turnkey benefits verification, pre-authorization coordination, and billing management, as well as the option of results interpretation and recommended therapy from a NovaSom clinician, enabling more comprehensive patient care within your practice. Physicians with questions may consult with the NovaSom Chief Medical Officer.
NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center & Telehealth Provider and is classified by CMS as an Independent Diagnostic Testing Facility.
By giving patients the option to conduct tests for OSA in their homes, we hope to identify and treat more of the millions of undiagnosed sufferers. Safeguard’s financial and operational support have augmented our traction to date, expanded our market penetration and ultimately impacted our patients’ quality of life.
– John Spitznagel, CEO, NovaSom